...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Definitive radiotherapy for squamous cell carcinoma of the pyriform sinus
【24h】

Definitive radiotherapy for squamous cell carcinoma of the pyriform sinus

机译:确定性放射疗法治疗梨状鼻窦鳞状细胞癌

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: To report the long-term results after definitive radiotherapy (RT) for pyriform sinus squamous cell carcinoma (SCC). Material and methods: The data concerning all patients treated for pyriform sinus SCC with RT with a curative intent between 1990 and 2006 were reviewed. Results: A total of 249 patients were included. The median follow-up is 6.5 years. Overall 123 patients had relapsed. For the entire population, the 5-year local control, regional control, freedom-from-distant metastasis, and overall survival rate were 68%, 69%, 78% and 38%, respectively. The 5-year local control rate for the 107 T1-T2 tumors was 85% (95% confidence interval (CI): 75-91). N stage was the main risk factor for the development of distant metastases, with a hazard ratio of 8.9 (95% CI: 2.1-39) and 15.6 (95% CI: 3.6-67.8) for N2 and N3 patients respectively. For patients with N2-N3 disease, pre-RT neck dissection improved regional control but not overall survival. Moderate to severe late complications occurred in 50 patients (28% of the patients without local relapse). Conclusion: A high local control rate can be achieved when treating T1-T2 hypopharynx cancers with definitive radiotherapy. The high rate of nodal and distant relapses among patients with N2-N3 disease warrants intensification of therapy.
机译:背景与目的:报告在梨状窦鳞状细胞癌(SCC)的明确放疗(RT)后的长期结果。资料和方法:回顾了1990年至2006年间所有治愈性梨状窦SCC并接受根治性治疗的患者的数据。结果:共纳入249例患者。中位随访时间为6.5年。总共有123例患者复发。对于整个人群,其5年局部控制,区域控制,远距离转移自由和总生存率分别为68%,69%,78%和38%。 107例T1-T2肿瘤的5年局部控制率为85%(95%置信区间(CI):75-91)。 N期是发生远处转移的主要危险因素,N2和N3患者的危险比分别为8.9(95%CI:2.1-39)和15.6(95%CI:3.6-67.8)。对于患有N2-N3疾病的患者,RT前颈清扫术可以改善区域控制,但不能改善整体生存率。 50例患者发生中度至严重的晚期并发症(28%的患者无局部复发)。结论:确定性放疗治疗T1-T2下咽癌可达到较高的局部控制率。 N2-N3病患者的淋巴结和远处复发率很高,因此有必要加强治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号